SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2018
For the full year ending March 31, 2018, on consolidated basis, the company expects net sales of JPY 15,860 million, operating income of JPY 1,440 million, ordinary income of JPY 1,320 million, net income attributable to owners of parent of JPY 630 million and net income per share of JPY 80.45.
For the second quarter of fiscal 2018, the company expects to pay dividend of JPY 12.50 per share compared to JPY 12.50 per share paid in last year.
For the year ending March 31, 2017, the company expects to pay dividend of JPY 12.50 per share compared to JPY 12.50 per share paid in last year.